RHOH and neoplasm: They designed ScFv(L19)-tTF, which displays a highly accumulated neovasculature a few hours after injection and led to whole tumor cells eradication in 30% of the mice treated in the absence of noticeable side effects at the highest doses of administration in three various kinds of tumors [273, 296].